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SIMON, A.B., ETAL.: Ventricular pacing in children. Ventricular pacing was performed in forty-one
children ranging from one day to twenty years of age (median age = 10]. Weight of the recipient at
implant ranged from 2 kg. to 86 kg. Indications included presyncope, syncope, dyspnea on exertion,
congestive heart failure, postoperative infra-Hisian heart bJocJt, and inadequate cardiac rate during
pharmacotherapy. Four patients died during foJJow-up, but no deaths were attributable to pacemaker
management. In contrast, 66% of the patients required more than one pacemaker reJated-operative
procedure, and 43% of leads implanted failed by 48 hours. Indications for permanent cardiac pacing in
this population at this time are symptomatic congenital AV block, symptomatic sinus node disease, and
AV block in the postoperative period. Technological developments which might reduce complications
seen in this population and electrophysiologic techniques which may better define indications for pac-
ing in children are also reviewed. (PACE, Vol, 5, November-December, 1982}
ventricular pacing, congenital AV block, sinus node disease, postoperative AV block
Permanent pacemaker implantation for the pal-
liative treatment of atrioventricular block and
sinus node disorders in children is an accepted
treatment modality. It is the purpose of this re-
port to review our experience with this tech-
nique in the pediatric population, to report our
experience with epicardial lead longevity in
children, and to compare it with lead perfor-
mance reports in adults, to present our policy for
pacemaker implantation in children, and to re-
view recent advances particularly relevant to
pacemaker management in children.
Materials & Methods
The records of all patients under the age of
twenty-one who required permanent ventricu-
lar pacing at the CS, Mott Children's Hospital or
the University Hospital of the University of
Michigan Medical Center from January 1, 1962
through December 31,1979 were reviewed. Data
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were summarized on precoded forms for subse-
quent computer analysis using methods pre-
viously described,'"'' The clinical indication for
pacing, the time course relative to prior cardiac
operative procedures, the nature of the asso-
ciated cardiac malformations, the frequency of
all cardiovascular operative procedures, and the
incidence of pulse generator and lead com-
plications were analyzed.
During the eighteen years of this study ad-
vances in surgical technique and available
devices, as well as evolving clinical criteria for
pacemaker implant, undoubtedly influenced the
clinical course of these patients.
Surgical techniques evolved during the peri-
od of the study; four cardiovascular surgeons
performed the implantation and, therefore, con-
siderable variability in the specific technique
employed is to be expected. The patients were
paced with either General Electric,* Med-
tronic,f Cordis,:}: Cardiac Pacemaker,** or
Coratomic*t pulse generators through General
*Ceneral Electric, New York, New York, U,S,A,
fMedtronic, Inc, Minneapolis, Minn,, U,S,A,
^Cordis Corp., Miami, Florida, U,S,A,
**Cardiac Pacemaker, Inc., St, Paul, Minn., U,S,A.
*tCoratomic, Inc., Indiana, Pa,, U,S,A,
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Electric, Medtronic, Cardiac Pacemaker, or
Cordis leads.
For the determination of lead performance,
the status of both active and redundant leads im-
planted after 1965 on which threshold data were
available was tabulated and an actuarial curve
calculated. Lead performance was calculated
from the day of implant to the day of failure or
end of the follow-up period, December 31,1980.
Failure was defined as a chronic threshold
greater than 5 volts either due to lead fracture or
high threshold ("exit block").
Since 1978 electrophysiologic study has been
used to identify the site of block in patients with
atrioventricular conduction disturbances, and to
evaluate sinus node function in patients with the
clinical manifestations of sick sinus syndrome.
Results
From 1962 through 1979 forty-one children
between tbe ages of one day to twenty years
(median age = 10 years) received a permanent
pacemaker at our institution. There were
twenty-four females and seventeen males. The
weight at implant ranged from 2 kg. in a six-day-
old boy to 86 kg. in an eighteen-year-old man.
Clinical indications for pacemaker implant at
our institution were revised periodically during
the study period. Cardiac symptoms such as pre-
syncope, syncope, dyspnea on exertion, and con-
gestive heart failure, as well as the association
of other congenital heart defects, in the pres-
ence of inadequate impulse formation and/or
impaired atrioventricular conduction, served as
the major impetus for pacemaker implant in 39
of the 41 patients. The remaining two patients
received pacemakers to preserve an adequate
cardiac rate during anti-arrhythmic pharmaco-
therapy.
A summary of the clinical diagnoses is pre-




A. Sinus node disease (symptomatic)
1. Sinus bradycardia
2. With ventricular arrhythmias
B. Atrioventricular block
1. Second degree type I
2. Complete atrioventricuiar biock
3. Complete atrioventricular block with other cardiac defect
Atriai septal defect 2
Patent ductus arteriosus 2
L-transposition of the great arteries 1
4. Compiete atrioventricuiar biock, iate
TOTAL
Post-operative Group
A. Sinus node disease
1. Endocardial Cushion Defect
2. D-transposition of the great arteries
B. Compiete Atrioventricuiar Block (symptomatic)
Tetraiogyof Faiiot
D-transposition of the great arteries
Ventricular septai defect
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three patients had symptomatic sinus brady-
cardia, two associated with ventricular arrhyth-
mias. Ten patients exhibited disturbances in
atrioventricular conduction, five associated
with congenital heart defects. The age at im-
plant in the non-surgical group was bimodal
with seven children under three years of age
and six over eleven years of age at initial
implant.
Twenty-four of the twenty-eight patients in
the surgical group required pacing for complete
atrioventricular block acquired at operation;
four patients required pacemaker support for
symptomatic surgically related sinus node dis-
ease, either because of bradycardia or for sup-
pressive pharmacotherapy of tachyarrhyth-
mias. Twenty-five of the patients have received
their initial implant since 1971 whereas the
other 16 were initially paced prior to 1971.
Although eighteen of twenty-eight post surgical
patients [seventeen with AV block and one with
sinus node dysfunction) received their pace-
makers within one year of the repair of their
structural heart disease, ten of these within
thirty days, the remaining ten (seven with AV
block and three with sinus node dysfunction)
did not require pacing until much later, five not
until eleven or more years after operation.
Among the ten patients who developed com-
plete heart block following operation but were
not immediately paced, nine did not become suf-
ficiently symptomatic to warrant pacing until
one month to five years following operation. The
other patient developed transient atrioven-
tricular block which resolved within two weeks
only to return ten years later.
Two patients in whom complete atrioven-
tricular block developed following surgery but
were not immediately paced, demonstrated
supra-Hisian block (within the atrioventricular
node) at electrophysiologic study, and required
pacemaker placement because of symptoms
(syncope in one, and dyspnea on exertion with a
fixed heart rate in the other). Two additional pa-
tients have surgical heart block and have not
been paced—one is asymptomatic and has
supra-Hisian block on electrophysiologic study,
and a second is well but refused study and pace-
maker implantation.
Operative Procedures
The major and minor cardiac and pacemaker
related surgical procedures performed in this
group of patients are tabulated in Table IL
Twenty-five of the forty-one patients required
Table II.
Frequency of operative procedures required for both Intracardiac repair and pacemaker reiated indications
during the study intervai 1962-1979. Pacemaker and cardiac procedures were not necessariiy separate. The












































* One required 6, one required 7 and a third 10.
** Two required 6, one required 10.
838 November-December 1982 PACE, Vol. 5
VENTRICULAR PACING IN CHILDREN
more than one pacemaker-related operative
procedure; six required four or more. Eighty
thoracotomies have been performed among
these forty-one patients either for surgical
repair of the congenital heart defect or for car-
diac pacing. When both pacing and cardiac pro-
cedures are combined, half the patients have
been operated upon three or more times.
Implantation Techniques & CompJications
The epicardial lead placement approach was
used as the initial mode of pacing in thirty-eight
of the forty-one patients, and the transvenous
approach was used initially in three. One pa-
tient was converted to transvenous pacing after
multiple lead failures with the epicardial tech-
nique. The manufacturer and lead models
utilized, and the frequency and mode of lead
failure are tabulated in Table III. Epicardial
leads were implanted in the left ventricle
through a lateral or anterolateral thoracotomy.
Although thresholds were measured with dif-
ferent devices during the study interval, acute
thresholds were accepted if less than 1 mV.
Twenty of the 74 leads utilized were of the
"sutureless" type and the remainder were myo-
cardial plunge electrodes from four different
manufacturers. The most commonly used lead,
the Medtronic Model 5913, has undergone seven
manufacturing modifications from 1972 to 1979
without model disignation change.*
During the study period the frequency of
myocardial lead failure has been high (Table
III]. Longevity data are available on fifty-eight
myocardial leads from four different manufac-
turers placed in thirty-five patients since 1965.
Actuarial analysis reveals that only 75% of the
leads were functioning 12 months after implant,
68% at 24 months after implant, and only 57% at
48 months after implant (Fig. 1]. Thereafter only
one additional myocardial lead has failed dur-
ing the follow-up interval. Ten of the sixteen
high threshold lead failures occurred in three
patients. There was no significant lead failure
difference since that date.
Our experience with transvenous pacing has
involved only four patients. Two adolescents re-
ceived transvenous right ventricular endocar-
dial pacing systems ten years after cardiac
repair (Tetralogy of Fallot in one, and atrial sep-
tal defect, secundum in the other] and are well
two years later. The third patient is reinarkable
for duration of the lead system. She received her
initial epicardial pacemaker in 1962 at age five
because of symptomatic complete heart block
following ventricular septal defect repair. She
was converted in 1965 to a transvenous pacing
*Medtronic Corporation—Personal communication.
Table III.
Epicardial lead performance in 35 of the 41 patients over the follow-up period after 1964. Five transvenous












































































Figure 1. Percent of normally functioning myocar-
dial leads related to time [months] computed by ac-
tuarial analysis. Numbers in parenthesis indicate the
number of leads at risk at each interval.
system after failure of multiple epicardial leads.
She has been continually paced from one trans-
venous electrode with an acceptable (less than 5
volts) threshold since. One patient with a trans-
venous lead expired within the first year follow-
ing implant of noncardiac causes.
Pacemaker wound infection was noted in
three patients. In each instance more than one
surgical procedure was required to remove the
old and re-implant a new pacing system.
Clinical Course FoJJowing Implant
Permanent pacing has been discontinued in
three patients since initial implant. One, a nine-
teen-year-old girl underwent repair of Tetralogy
of Fallot in 1963, followed by complete heart
block. Repeated failure of epicardial implants
led to patient refusal of further implant. She re-
mains asymptomatic and unpaced. The second
was a two-and-a-half month old infant with
ventricular tachycardia alternating with sinus
rhythm and transient 2:1 block. Pacing failure
developed soon after implant and high thresh-
olds (greater than 5 volts) were measured eigh-
teen months later when the generator was
removed. She has been in normal sinus rhythm
with a right bundle branch block and first
degree AV block since that time. Quinidine has
controlled her ventricular arrhythmia. The third
patient developed complete atrioventricular
block following Mustard procedure at ten
months of age for transposition of the great
arteries. A pacemaker was implanted ten days
following operation, but pacing ceased six
months later because of lead failure. Normal
sinus rhythm had reappeared and has persisted
for five years. Two additional children have had
resolution of their postoperative atrioventricu-
lar block with appropriate inhibition of their de-
mand pacemakers; the opportunity to discon-
tinue the pacing system has not yet arisen.
Mortality
There have been four deaths (10%) in the
series, none attributable to pacemaker mal-
function. A fourteen-year-old boy with single
ventricle, transposition of the great arteries, and
pulmonary stenosis, had a pacemaker implanted
16 days after ventricular septation and a
pulmonary valve replacement. He died sudden-
ly thirty-nine months later. Ten days before his
death his pacemaker had been functioning nor-
mally, but severe pulmonary artery hyperten-
sion and congestive heart failure were persis-
tent prior to death. The second death was in a
nineteen-year-old girl with Kearns syndrome,'
who died four months after pacemaker implanta-
tion due to bronchopneumonia and pan-
creatitis. The third was a three-year-old infant
with ventricular septal defect, corrected trans-
position, atrial septal defect, and congenital
atrioventricular block who had a permanent
pacemaker implanted at the time of a Blalock-
Taussig anastomosis. She died of pneumonia
four months later. The fourth death occurred in
a seventeen-year-old boy with Down's syn-
drome, ventricular septal defect (endocardial
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cushion type), pulmonary artery hypertension,
and mitral valve replacement. Intermittent com-
plete heart block required a pacemaker implant
to assure adequate heart rate shortly after
operation. Recurrent diptheroid sepsis and ven-
tricular arrhythmias, controlled hy quinidine,
complicated the 20-month postoperative course.
At the time of his death, atrioventricular con-
duction was intact and the pacemaker was func-
tioning normally in the demand mode at an es-
cape rate of 40 beats per minute. The remaining
37 patients are alive and fully engaged in age-
appropriate activities except for vigorous com-
petive sports.
Discussion
Previous reviews of the status of pediatric pa-
tients requiring ventricular pacing have empha-
sized the specific etiology of the rhythm dis-
turbances,'•' technical aspects of the age-
specific implantation problems of children,'-"
the natural history of arrhythmias which require
pacing,'"''" as well as the long-term experience in
pediatric patients who have received permanent
pacemakers."''" Our data underscore the high
morbidity but low mortality and often life-
saving intervention that accrues to children fol-
lowing ventricular pacing. Thirty-four children
required ventricular pacing because of atrio-
ventricular block, twenty-four surgically in-
duced. Three of the four patients with post-sur-
gical sinus node disease became symptomatic
greater than three years after the operation and
greater than ten years in two, suggesting that this
abnormality may become more prevalent as this
group of patients survives into adulthood. The
bimodal distribution of age at initial implant, es-
pecially in those patients with congenital com-
plete heart block, suggest that intrinsic escape
rates that result in symptoms are either present
very early in life or do not emerge until
adolescence or young adult life.'"
The interval from cardiac repair to pace-
maker implant in the surgical group may be
related to the site of block. In contrast to the ex-
perience of others,* seven of our patients who
developed surgical complete heart block did not
require pacing until late (greater than one year)
in the follow-up period; two of these patients
have undergone electrophysiologic study and
both demonstrated supra-Hisian complete
heartblock.
The epicardial lead approach using a variety
of lead systems has not been entirely satisfac-
tory. The survival of epicardial leads in this
series is similar to that reported for other paced
children during a comparable interval,"'" but
far worse than the epicardial experience
reported for adults. Magilligan et al.'" reported
lead failure in 8 of 100 adults with hoth sutured
and sutureless (Medtronic models 5913,6913 and
6917) electrodes after 30-64 months. Edwards
and Davies" reported 13% epicardial lead fail-
ure rate at 30 months (Medtronic models 6913,
6914 and 6917). Mansour et al." experienced
only four lead failures in 300 patients using the
Medtronic 6917 sutureless electrode. Using the
same lead Lawrie et al." reported only a 3.9%
failure rate at 39 months on initial implants, but
a 25% failure rate on patients referred for
repeated procedures. Interestingly, two pa-
tients in their series had failure of both leads. In
their well documented series, lead failure, con-
sisting of high thresholds in all, occurred in 7.2%
of 400 leads by 39 months.
For incompletely understood reasons, ten pa-
tients in our series developed high thresholds
with multiple implants. Excluding the three pa-
tients paced prior to 1965, when the lead frac-
ture rate was higher and not representative of
current experience, two patients have required
two, and one patient three, thoracotomies within
the first year of pacing for lead failure due to
thresholds exceeding the five volt output of stan-
dard pulse generators available at the time.
While one patient could be converted to a high
output (10 volt) pulse generator, under local
anesthesia, the remaining patients required
repeat thoracotomy for new lead implantation.
It is possible that this frequency of lead re-
placement in the future might not be as high now
that multiprogrammable pulse generators whose
output and pulse duration can be raised non-
invasively after implantation are available. Ob-
viously this benefit of technology would be help-
ful only for those patients who developed only a
modest increase in threshold, and not to those
with lead failure due to lead fracture or ex-
tremely high thresholds.
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Possible factors which may contribute to poor
myocardial lead performance in children in-
volve surgical technique as well as available
technology.
Early myocardial electrodes required small
stab wounds into the myocardium for insertion,
followed by securing of the electrode to the myo-
cardium with sutures. This method may result in
hemorrhage, necrosis, and fibrosis at the site of
placement. A rapid decrease in current density
at the electrode-myocardial interface leading to
failure of myocardial capture and subsequent
system revision was not infrequently the result."
Similar techniques are used in adults, and this
explanation alone cannot explain the higher fre-
quency of threshold rises in children seen in this
series. Changes in electrode design, particu-
larly the sutureless electrode, have simplified
insertion and may be less traumatic to the myo-
cardium, although data to support this conclu-
sion are not available. Placement of the lead
through the diaphragm to the generator pocket
in the abdominal wall, rather than immediately
beneath the ribs, removes a fulcrum on which
the lead may wear and may reduce lead frac-
ture. Creation of the abdominal generator
pocket immediately pre-peritoneal, beneath the
muscle layers of the abdominal wall rather than
subcutaneously, has facilitated wound closure,
especially in infants and small children, and
probably has reduced the incidence of wound
dehiscence and generator pocket infection." This
technique has been facilitated by miniaturiza-
tion of the pulse generators, achieved primarily
by the application of micro-circuitry, and smal-
ler but longer lasting power sources. A number
of additional developments during the study in-
terval have improved the long-term outlook for
the paced child. The development of double or
triple helicoil lead wires has apparently
lengthened the life span of an implanted lead.
The development of a simple pacemaker analy-
sis system assists the surgeon in determination
of the causes of pacing system malfunction and
more accurately tests threshold of stimulation at
the time of initial lead placement.
As suggested by our own limited experience,
as well as that of others,"'" there appears to be a
role for transvenous patients in this age group.
Repeated electrode repositioning which might
be required with late displacement due to trun-
cal growth in children would certainly appear to
be preferable to the multiple thoracotomies re-
quired for epicardial lead placement. Percu-
taneous insertion of permanent leads now ob-
viates the problem of venous access unavail-
ability in this age group." Certainly, patients
without right-to-left shunts who are over ten
years of age, and perhaps younger, would be ac-
ceptable candidates for transvenous pacing.
New positive fixation electrodes have substan-
tially reduced the complication rates of trans-
venous approaches in adults and may hold
promise in growing children. Furman and
Young" reported no excess lead difficulties us-
ing the transvenous technique in 12 of 13 pedi-
atric patients paced transvenously—only one re-
quired conversion to epicardial leads because of
repetitive displacement.
Based on this experience and that of others,'^
the following is our current approach in the
management of disturbances in impulse forma-
tion and conduction in children. The initial man-
agement relates to etiology. Patients with con-
genital complete heart block are paced upon the
appearance of presyncope, syncope, congestive
heart failure, or other rate related symptoms.
Patients with sinus node disorders, either con-
genital, acquired, or surgically induced, receive
a pacemaker upon the appearance of symptoms
or to insure adequate impulse formation during
pharmocotherapy for symptomatic tachy-
arrhythmias. Both groups of patients undergo
electrophysiologic study prior to implant to
identify the intrinsic escape mechanism, to
localize the site of block, if present, and to assess
intrinsic pacemaker response to rapid atriai pac-
ing, atropine, isoproterenol infusion, and exer-
cise. Permanent pacing for bradycardia alone in
the isolated congenital AV block group has not
been employed, despite an apparent higher risk
of progression to a symptomatic course in this
subgroup."
Surgically induced rhythm disturbances are
analyzed for time of onset, severity, adequacy of
escape rhythm, response to exercise, and site of
block (if present]. Transient [less than three
weeks following surgery) but stable impulse
formation and conduction disturbances are
managed in the immediate postoperative peri-
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od with temporary transthoracic epicardial
wires (atrial or ventricular, depending upon the
site of abnormality] and, prior to discharge, by
ambulatory monitoring to insure adequate im-
pulse formation and propagation. If complete
atrioventricular block persists beyond three
weeks, electrophysiologic study is recom-
mended to identify the site of block; if surgical
heart block is intra-Hisian or below the His, a
permanent pacemaker is implanted. If the block
is supra-Hisian, the patient asymptomatic, and
the intrinsic pacemaker escape satisfactory by
Holter monitoring, the parents are advised of
both our experience and the reported experi-
ence of surgical heart block.̂ -̂'̂  Early in our ex-
perience (prior to the era of electrophysiologic
study) pacemakers were withheld unless symp-
toms dictated their insertion. At present we
recommend implant in the supra-Hisian group
even in the absence of symptoms; despite this
recommendation, the families of two children
have refused implant; both children are well
five and ten years after surgery. This experi-
ence, though small, suggests that supra-Hisian
heart block in the absence of symptoms, with an
adequate escape rate, may be less life-
threatening than infra-Hisian, or undifferen-
tiated surgical heart block, a finding shared by
DriscoU et al.'^ Lesser degrees of conduction ab-
normalities such as bifascicular block or tri-
fascicular disease, are followed closely by
electrophysiologic studies at times of postoper-
ative catheterization and by periodic ambula-
tory monitoring. This approach is designed to
identify high-risk patients in need of pace-
maker support without submitting all individ-
uals with impulse formation and conduction
abnormalities to long-term pacemaker manage-
ment with its attendant high cost and morbidity.
Although we have utilized isotopic pulse gen-
erators in six patients in this series, we no longer
implant this type of unit. The pulse generators
are more expensive than programmable lithium
powered pulse generators; their major advan-
tage, a long-life power source, is offset by the
fact that the major complication of the pacing
system in this age group in this series, which was
almost exclusively with epicardial leads, is
related to the development of high lead thresh-
olds, not to the limited life span of the power
source. Expected advances in lead systems and
anticipated benefits from dual chamber pacing
and flexibility obtained with pulse generator
programmability is lost by reliance on this type
of unit. Furthermore, although we know of no
data indicating that nuclear-powered units con-
stitute a health danger to the patient, the chronic
(decades) use of this device in children may
have risks unidentified at the present time.
Finally, the reduction in random electronic mal-
function and premature battery depletion as a
result of advances in pulse generator circuitry
design and manufacture, as well as the avail-
ability of telephone monitoring for early pacing
system malfunction detection, have all simpli-
fied routine follow-up of the pacemaker pa-
tient. In summary, the childhood population re-
quiring permanent pacing consists of patients
with congenital and surgically induced abnor-
malities of impulse formation and conduction.
The decision to implant a permanent pace-
maker in this age group should be made with an
appreciation of the rate of associated morbidity
unique to children and the current state of pac-
ing technology. Today, utilizing historical, non-
invasive, and electrophysiologic data, one can
develop a rational basis for the institution of
pacing in children. Improvements in diagnosis
of rhythm disturbances in children, as well as
present and future technical advances in pacing
system design, render this therapeutic techni-
que applicable to all age groups."
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